Literature DB >> 9494830

Kaposi's sarcoma and human herpesvirus-8.

R M Greenblatt1.   

Abstract

KS is a major cause of morbidity and mortality among AIDS patients and a treatment problem in the sporadic cases that are not associated with HIV. All four forms of the disease are linked to a newly described herpesvirus, HHV-8 or KSHV, via strong epidemiologic associations and biologic plausibility as a causal agent. HHV-8 is also epidemiologically associated with body cavity-based lymphomas, which are almost unique to AIDS, and Castleman's disease. Existing radiation and chemotherapeutic treatments of KS are only partially effective and cause significant adverse effects. New preventive approaches and therapies aimed at inhibiting HHV-8 may be effective. New treatments that interfere with the molecular mechanisms that drive KS may, in the future, provide the best opportunities to control the disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9494830     DOI: 10.1016/s0891-5520(05)70409-8

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  5 in total

1.  The pathogenesis of Kaposi's sarcoma.

Authors:  S Rodman; C J Cockerell
Journal:  West J Med       Date:  1998-10

2.  Regression of a murine gammaherpesvirus 68-positive b-cell lymphoma mediated by CD4 T lymphocytes.

Authors:  K A Robertson; E J Usherwood; A A Nash
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma.

Authors:  T Y Yang; S C Chen; M W Leach; D Manfra; B Homey; M Wiekowski; L Sullivan; C H Jenh; S K Narula; S W Chensue; S A Lira
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

4.  Clinicopathological analysis of 114 cases of typical Kaposi's sarcoma in Xinjiang Uygur autonomous region, China.

Authors:  Jun-Wei Fan; Xue-Feng Wan; Bian Yi; Jin-Cheng Dong; Palida Abulize
Journal:  Mol Med Rep       Date:  2017-08-18       Impact factor: 2.952

5.  Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.

Authors:  Janet M Wojcicki; Rob Newton; Margaret I Urban; Lara Stein; Martin Hale; Moosa Patel; Paul Ruff; Ranjan Sur; Dimitra Bourboulia; Freddy Sitas
Journal:  BMC Infect Dis       Date:  2003-09-12       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.